Solid Biosciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone, to the 39th Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Tessa Romero and Matt Bannon from the team.
Our next presenting company is Solid Biosciences. And speaking on behalf of the company, we have CEO, Ilan Ganot.
Before I turn it over to Ilan, I just wanted to highlight that for the listeners on the webcast, if you'd like me to ask a question on your behalf, please use Ask a Question feature in the portal, and I'd be happy to do that.
With that, I'll turn it over to you, Ilan.
Thank you, Anupam, and thanks so much, JPMorgan, for hosting this conference. Clearly, a very peculiar one indeed.
It's a pleasure to present the progress we made at Solid over the last few years, especially in 2020, in the face of the pandemic. And I will try to highlight the slides I'm
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |